Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Long-term, Open-label, Safety Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorder (NMOSD)CNS demyelinating autoimmune disease, acute transverse myelitis, autoimmune disease, autoimmune disorder of the nervous system, cranial nerve neuropathy, demyelinating disease, eye disorder, immune system disorder, nervous system disorder, neuromyelitis optica, optic nerve disorder, optic neuritisActive, not recruitingPhase 42025-11-21NCT06180278

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Amgen180

11 results · Page 1 of 1

Swipe the table sideways for more columns.